United Asset Strategies, Inc. Gilead Sciences, Inc. Transaction History

United Asset Strategies, Inc.

$1.07 Billion
Q3 2024

A detailed history of United Asset Strategies, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, United Asset Strategies, Inc. holds 31,378 shares of GILD stock, worth $2.82 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

31,378

Previous 31,639 0.82%

Holding current value

$2.82 Million

Previous $2.17 Million 21.2%

% of portfolio

0.25%

Previous 0.22%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$66.59 - $83.99 $17,379 - $21,921	-261 Reduced 0.82%	31,378 $2.63 Million
Q2 2024 Aug 01, 2024	SELL	$63.15 - $72.88 $993,286 - $1.15 Million	-15,729 Reduced 33.21%	31,639 $2.17 Million
Q1 2024 Apr 23, 2024	BUY	$71.58 - $87.29 $60,485 - $73,760	845 Added 1.82%	47,368 $3.47 Million
Q4 2023 Jan 30, 2024	SELL	$73.27 - $83.09 $188,890 - $214,206	-2,578 Reduced 5.25%	46,523 $3.77 Million
Q3 2023 Nov 07, 2023	BUY	$73.94 - $80.67 $1.52 Million - $1.66 Million	20,520 Added 71.8%	49,101 $3.68 Million
Q2 2023 Jul 25, 2023	SELL	$76.01 - $86.7 $12,693 - $14,478	-167 Reduced 0.58%	28,581 $2.2 Million
Q1 2023 Apr 25, 2023	BUY	$77.31 - $88.08 $3,401 - $3,875	44 Added 0.15%	28,748 $2.39 Million
Q4 2022 Jan 26, 2023	BUY	$62.32 - $89.47 $4,300 - $6,173	69 Added 0.24%	28,704 $0
Q3 2022 Oct 24, 2022	BUY	$59.54 - $68.01 $6,668 - $7,617	112 Added 0.39%	28,635 $1.77 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $55,988 - $63,059	970 Added 3.52%	28,523 $1.76 Million
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $1.6 Million - $2 Million	27,553 New	27,553 $1.64 Million
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $1.23 Million - $1.43 Million	-17,037 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $1.07 Million - $1.37 Million	17,037 New	17,037 $1.27 Million
Q3 2019 Nov 01, 2019	SELL	$62.51 - $69.0 $3.35 Million - $3.69 Million	-53,527 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$61.87 - $69.38 $88,474 - $99,213	-1,430 Reduced 2.6%	53,527 $3.62 Million
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $976,781 - $1.09 Million	-15,621 Reduced 22.13%	54,957 $3.57 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $274,367 - $358,028	-4,532 Reduced 6.03%	70,578 $4.42 Million
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $224,460 - $248,519	3,149 Added 4.38%	75,110 $5.8 Million
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $455,133 - $530,895	7,015 Added 10.8%	71,961 $5.1 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $227,843 - $277,766	3,128 Added 5.06%	64,946 $4.9 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $640,919 - $752,348	-9,008 Reduced 12.72%	61,818 $4.43 Million
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $5.11 Million - $6.05 Million	70,826	70,826 $5.74 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Asset Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Asset Strategies, Inc. with notifications on news.

Account

United Asset Strategies, Inc. Gilead Sciences, Inc. Transaction History